Ipratropium Bromide Spray
Product Images NDC 69238-2016

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide (NDC 69238-2016). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Ipratropium Bromide Nasal Solution 21 Mcg Per Spra 1)

FDA Label Image

Figure 1 (Ipratropium Bromide Nasal Solution 21 Mcg Per Spra 2)

FDA Label Image

Figure 2 (Ipratropium Bromide Nasal Solution 21 Mcg Per Spra 3)

FDA Label Image

Figure 3 (Ipratropium Bromide Nasal Solution 21 Mcg Per Spra 4)

FDA Label Image

Figure 4 (Ipratropium Bromide Nasal Solution 21 Mcg Per Spra 5)

FDA Label Image

Label (Ipratropium Bromide Nasal Solution 21 Mcg Per Spra 6)

Label (Ipratropium Bromide Nasal Solution 21 Mcg Per Spra 6)
This is a description of a medication called Ipratropium Bromide Nasal Solution/Nasal Spray in which each spray contains 21 meg of Ipratropium Bromide. It is available in a 30 mL bottle and has 345 metered sprays. The medication must be kept between 20°C and 25°C to avoid damage. It is distributed by Amneal Pharmaceuticals in Bridgewater, NJ. The accompanying full prescribing information and patient instructions must be read before administering. A warning is issued to avoid spraying the medication in or around the eyes.*
FDA Label Image

Carton (Ipratropium Bromide Nasal Solution 21 Mcg Per Spra 7)

Carton (Ipratropium Bromide Nasal Solution 21 Mcg Per Spra 7)
This is a description of a nasal solution called Ipratropium Bromide Nasal Solution produced by Amneal Pharmaceuticals. It is a nasal spray that contains 21 mcg/spray of ipratropium bromide USP. The solution is pH adjusted with hydrochloric acid and/or sodium hydroxide and also contains benzalkonium chloride, edetate disodium, purified water, and sodium chloride. The recommended dose is two sprays per nostril or three times a day. Patients are advised to avoid spraying the solution around the eyes. The spray should be stored at 20°C to 25°C, and freezing should be avoided. The full prescribing information and patient instructions should be referred to before use. The NDC number for this product is 69236.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.